Specific code icon 2014 ICD-10-CM Diagnosis Code Z51.11

Encounter for antineoplastic chemotherapy

  • Z51.11 is a billable ICD-10-CM code that can be used to specify a diagnosis.
  • On October 1, 2014 ICD-10-CM will replace ICD-9-CM in the United States, therefore, Z51.11 and all other ICD-10-CM codes should only be used for training or planning purposes until then.
Present On Admission
  • Z51.11 is considered exempt from POA reporting.
ICD-10-CM Z51.11 is grouped within Diagnostic Related Group(s) (MS-DRG v30.0):
  • 826 Myeloprolif disord or poorly diff neopl with maj o.r. proc with mcc
  • 827 Myeloprolif disord or poorly diff neopl with maj o.r. proc with cc
  • 828 Myeloprolif disord or poorly diff neopl with maj o.r. proc without cc/mcc
  • 829 Myeloprolif disord or poorly diff neopl with other o.r. proc with cc/mcc
  • 830 Myeloprolif disord or poorly diff neopl with other o.r. proc without cc/mcc
  • 837 Chemo with acute leukemia as sdx or with high dose chemo agent with mcc
  • 838 Chemo with acute leukemia as sdx with cc or high dose chemo agent
  • 839 Chemo with acute leukemia as sdx without cc/mcc
  • 846 Chemotherapy without acute leukemia as secondary diagnosis with mcc
  • 847 Chemotherapy without acute leukemia as secondary diagnosis with cc
  • 848 Chemotherapy without acute leukemia as secondary diagnosis without cc/mcc
Convert ICD-10-CM Z51.11 to ICD-9-CM
The following ICD-10-CM Index entries contain back-references to ICD-10-CM Z51.11: